Additional file 2 of Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma
| Title: | Additional file 2 of Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma |
|---|---|
| Authors: | Kimberley M. Hanssen; Jayne Murray; Ruby Pandher; Stephanie Alfred; Laura D. Gamble; Jennifer Brand; Erin Mosmann; Frances K. Kusuma; Crystal Mak; Adam Kearns; Alvin Kamili; Caroline Atkinson; Alexis Z. Minchaca; Jean Bertoldo; David S. Ziegler; Francis Mussai; Paul N. M. Cheng; Murray D. Norris; Jamie I. Fletcher; Michelle Haber |
| Publication Year: | 2025 |
| Collection: | VIVO: Figshare |
| Subject Terms: | Biochemistry; Medicine; Cell Biology; Pharmacology; Cancer; Virology; Information Systems not elsewhere classified; Neuroblastoma; Arginine; Arginase; Metabolism; Preclinical testing; Patient-derived xenografts |
| Description: | Supplementary Material 2: Figure S2. BCT-100 anti-proliferative effect is not rescued by aspartate supplementation |
| Document Type: | still image |
| Language: | unknown |
| DOI: | 10.6084/m9.figshare.29923502.v1 |
| Availability: | https://doi.org/10.6084/m9.figshare.29923502.v1; https://figshare.com/articles/figure/Additional_file_2_of_Arginine_depletion_potentiates_standard-of-care_chemo-immunotherapy_in_preclinical_models_of_high-risk_neuroblastoma/29923502 |
| Rights: | CC BY + CC0 |
| Accession Number: | edsbas.CFD1C763 |
| Database: | BASE |